Physician profile
John C Munshower
NPI 1427118074
$1,315.35
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2021: $607 · 2023: $100 · 2024: $24.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $525.00 | 2021 | |
| Allergan, INC. | $253.63 | 2019 | |
| Pfizer INC. | $235.63 | 2019-2023 | |
| Glaxosmithkline, LLC. | $81.46 | 2019-2023 | Arexvy |
| Astrazeneca Pharmaceuticals Lp | $50.70 | 2019 | |
| Inspire Medical Systems, INC. | $48.63 | 2023-2024 | Inspire |
| Gilead Sciences, INC. | $27.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.40 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $27.34 | 2021 | |
| Abbott Laboratories | $19.91 | 2021 | |
| Dynavax Technologies Corporation | $18.21 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Munshower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.